Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics of the Mycoplasma pneumoniae Epidemic from 2019 to 2020 in Korea: Macrolide Resistance and Co-Infection Trends
So–Youn Shin, Sun Hoe Koo, Yong-Jin Yang, et al.
Antibiotics (2023) Vol. 12, Iss. 11, pp. 1623-1623
Open Access | Times Cited: 18

Showing 18 citing articles:

Post-COVID-19 Pandemic Rebound of Macrolide-Resistant Mycoplasma pneumoniae Infection: A Descriptive Study
Fanfan Xing, Kelvin Hei‐Yeung Chiu, Chaowen Deng, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 262-262
Open Access | Times Cited: 14
Epidemiological and clinical characteristics of hospitalized pediatric patients with Mycoplasma pneumoniae pneumonia before and after the COVID-19 pandemic in China: a retrospective multicenter study
Yuqian Zhang, Chenglei Su, Yang Zhang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Mycoplasma pneumoniae infection in adult inpatients during the 2023–24 outbreak in France (MYCADO): a national, retrospective, observational study
Ariane Gavaud, Michal Holub, Antoine Asquier-Khati, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Disease burden and macrolide resistance of Mycoplasma pneumoniae infection in adults in the Asia-Pacific region
Chih-Cheng Lai, Chun-Chung Hsueh, Chi‐Kuei Hsu, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 2, pp. 107205-107205
Closed Access | Times Cited: 6
Critical Insights from Recent Outbreaks of Mycoplasma pneumoniae: Decoding the Challenges and Effective Interventions Strategies
Ravi Kant, Naveen Kumar, Yashpal Singh Malik, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107200-107200
Open Access | Times Cited: 5
Clinical Characteristics and Laboratory Diagnoses of Pediatric Patients Hospitalized During an Outbreak of Mycoplasma pneumoniae
Tze‐Chiang Meng, Yuanhong Xu
Apmis (2025) Vol. 133, Iss. 1
Closed Access
Trends in Mycoplasma pneumoniae infections in pediatric patient preceding, during, and following the COVID-19 pandemic: a comprehensive longitudinal analysis
Jianwei Zhang, Ruoya Wu, Liyan Mo, et al.
Microbiology Spectrum (2025)
Open Access
Synergistic impact of macrolide resistance and H3N2 infection on M. pneumoniae outbreak in children
Jiali Chen, Ying-Dan Wang, Juan Cheng, et al.
Microbiology Spectrum (2025)
Open Access
<i>Mycoplasma </i><i>p</i><i>neumoniae</i> Pneumonia and Co-Infection with Post-COVID-19: A Single Centre Analysis
Agness Nicholaus Kanusya, Abdishakur Abdukadir Muse, Bibek Dhar Shrestha, et al.
International Journal of Clinical Medicine (2025) Vol. 16, Iss. 02, pp. 154-170
Open Access
Elucidating the Role of Nrf2 Signaling Pathway in Mycoplasma Infections
Sarmistha Saha, Nadezhda Sachivkina, Olga Kuznetsova, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access
Respiratory pathogen analysis in pediatric inpatients unraveled the infection pattern of Mycoplasma pneumoniae post the COVID-19 pandemic
Qihong Chen, Ruizhi Xu, Ying Gu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 3
Antibiotic resistance and viral co-infection in children diagnosed with pneumonia caused by Mycoplasma pneumoniae admitted to Russian hospitals during October 2023—February 2024
Elena V. Korneenko, Irina Rog, Ivan K. Chudinov, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Influence of non-pharmaceutical interventions on epidemiological characteristics of Mycoplasma pneumoniae infection in children during and after the COVID-19 epidemic in Ningbo, China
Min Jiang, Hui Zhang, Fangfang Yao, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 3
A comprehensive review of Mycoplasma pneumoniae infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis
Zai-Qiang Guo, Shun-Yi Gu, Zhihua Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from Vietnam
Duy T. Dao, H. Le, Minh‐Hai Nguyen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The Epidemiological Characteristics of Mycoplasma Pneumoniae Infection and Coinfection among Children in Central China from 2018 to 2023
Jieyu Mao, Zhili Niu, Mengling Liu, et al.
Research Square (Research Square) (2024)
Closed Access | Times Cited: 1
Marine-Derived Sulfated Glycans Inhibit the Interaction of Heparin with Adhesion Proteins of Mycoplasma pneumoniae
Jiyuan Yang, Yuefan Song, Ke Xia, et al.
Marine Drugs (2024) Vol. 22, Iss. 5, pp. 232-232
Open Access
Chest Computed Tomography Radiomics for Determining Macrolide Resistance-Associated Gene Mutation Status in Children with Mycoplasma pneumoniae Pneumonia: A Two-Center Study
Haoru Wang, Leilei Zhao, Yanlin Yang, et al.
Academic Radiology (2024) Vol. 31, Iss. 9, pp. 3774-3782
Closed Access
Development and Validation a Machine Learning Nomogram Model to Differentiation Mycoplasma Pneumoniae Coinfection with Other Pathogen in Children Patients
Wenbei Xu, Xiaohan Liu, Ling-Jian Meng, et al.
Research Square (Research Square) (2024)
Open Access
Page 1

Scroll to top